These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 27817159
21. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain. Finnema SJ, Stepanov V, Ettrup A, Nakao R, Amini N, Svedberg M, Lehmann C, Hansen M, Knudsen GM, Halldin C. Neuroimage; 2014 Jan 01; 84():342-53. PubMed ID: 23994452 [Abstract] [Full Text] [Related]
23. Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193. Hostetler ED, Fan H, Joshi AD, Zeng Z, Eng W, Gantert L, Holahan M, Meng X, Miller P, O'Malley S, Purcell M, Riffel K, Salinas C, Williams M, Ma B, Buist N, Smith SM, Coleman PJ, Cox CD, Flores BA, Raheem IT, Cook JJ, Evelhoch JL. Mol Imaging Biol; 2016 Aug 01; 18(4):579-87. PubMed ID: 26596571 [Abstract] [Full Text] [Related]
25. Development of a series of novel carbon-11 labeled PDE10A inhibitors. Stepanov V, Miura S, Takano A, Amini N, Nakao R, Hasui T, Nakashima K, Taniguchi T, Kimura H, Kuroita T, Halldin C. J Labelled Comp Radiopharm; 2015 May 15; 58(5):202-8. PubMed ID: 25891816 [Abstract] [Full Text] [Related]
26. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18F-MNI-659 and 11C-raclopride with correction for partial volume effect. Fazio P, Schain M, Mrzljak L, Amini N, Nag S, Al-Tawil N, Fitzer-Attas CJ, Bronzova J, Landwehrmeyer B, Sampaio C, Halldin C, Varrone A. Neuroimage; 2017 May 15; 152():330-339. PubMed ID: 28254508 [Abstract] [Full Text] [Related]
28. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. Gallezot JD, Bottlaender M, Grégoire MC, Roumenov D, Deverre JR, Coulon C, Ottaviani M, Dollé F, Syrota A, Valette H. J Nucl Med; 2005 Feb 15; 46(2):240-7. PubMed ID: 15695782 [Abstract] [Full Text] [Related]
30. Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging. Andrés JI, De Angelis M, Alcázar J, Iturrino L, Langlois X, Dedeurwaerdere S, Lenaerts I, Vanhoof G, Celen S, Bormans G. J Med Chem; 2011 Aug 25; 54(16):5820-35. PubMed ID: 21777010 [Abstract] [Full Text] [Related]
31. Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study. Persson J, Szalisznyó K, Antoni G, Wall A, Fällmar D, Zora H, Bodén R. Eur Arch Psychiatry Clin Neurosci; 2020 Jun 25; 270(4):451-459. PubMed ID: 31119377 [Abstract] [Full Text] [Related]